glp-1 muscle mass loss Study finds receptor agonists target fat over for weight Some people taking GLP-1 weight

Canada benefits from government price controls leading to lower patient costs, though some newer GLP-1s may be less accessible or require special authorization

Data Availability Statement The data supporting the findings of this study are available on the websites mentioned in the References section.

Overall, GLP-1RAs clearly enhance DNA repair and reduce oxidative stress, but their impact on RNA-processing defects remains uncertain

Novo Nordisk filed its New Drug Application with the FDA on 18 December 2025, based on data from the REDEFINE 1 trial

Caffeine as a Laxative Coffee acts as a stimulant and laxative for some

Its growing cardiovascular-outcomes evidence, combined with expanding reimbursement and manufacturing capacity, positions it to capture an estimated 44% share of global obesity GLP-1 sales by 2035